patent/LV-15384-A

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49ebd0fd2163d3c8e4337262b0603363
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
filingDate	2017-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb587cedcd9c3b632ce707d92dd06984 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45ea22432c8b304c7b07f852f199366b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fded7280f772220f091e90b0d3e022d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_958a3db1f64e473d2dcbfee227d1c282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39ecb8b77c49b6f6eca19c4a5c922856 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a276f111a2ab147698ba2fecb6824335
publicationDate	2019-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	LV-15384-A
titleOfInvention	1-Acetyl-5-nitro-4-phenyl-3-pyrolin-2-one for use in cancer treatment
abstract	The invention relates to the use of medicine, namely, the use of 1-acetyl-5-nitro-4-phenyl-3-pyrolin-2-one for the treatment of cancer, based on the inhibitory properties of the metalloproteinase and angiogenesis of this compound.
priorityDate	2017-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430385494 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134613113

Total number of triples: 19.